Menu

Experience

Barbara Kosacz

    • Cell Design Labs Sells to Gilead 


    • Versartis $145 Million IPO 


    • Principia Biopharma – $122 Million IPO 


    • DBV Technologies Completes Concurrent Public Offerings 


    • Aduro Completes $137 Million IPO 


    • Bristol Meyers Enters Agreement with Five Prime 


    • Avidity Biosciences Licensing and Research Collaboration with Eli Lilly 


    • Medivation Agrees to Sell to Pfizer for $14 Billion 


    • Genocea Biosciences IPO 


    • Atreca - $125 Million IPO 


    • NGM Biopharmaceuticals - $107 Million IPO 


    • Alpine Immune Sciences in its Collaboration and License Agreement with Adaptimmune 


    • 23andMe in its Multi-year Collaboration with GSK 


    • Adaptive Biotechnologies Announces Strategic Collaboration with Genentech 


    • Arcus Biosciences Announces 10-year Partnership with Gilead